Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study-Reference-Cited by-同舟云学术

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

Published:2014-08-14 Issue:6 Volume:11 Page:600
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Fiandaca Massimo S.¹,Kapogiannis Dimitrios²,Mapstone Mark³,Boxer Adam⁴,Eitan Erez²,Schwartz Janice B.⁵,Abner Erin L.⁶,Petersen Ronald C.⁷,Federoff Howard J.¹,Miller Bruce L.⁴,Goetzl Edward J.⁵

Affiliation:

1. Departments of Neurology and Neuroscience Georgetown University Medical Center Washington DC USA

2. Clinical Research Branch, Intramural Research Program National Institute on Aging Baltimore MD USA

3. Department of Neurology University of Rochester School of Medicine and Dentistry Rochester NY USA

4. Department of Neurology Memory and Aging Center, UCSF Medical Center San Francisco CA USA

5. Department of Medicine UCSF Medical Center and the Jewish Home of San Francisco San Francisco CA USA

6. Department of Neurology, Sanders-Brown Center on Aging University of Kentucky Lexington KY USA

7. Department of Neurology Mayo Clinic Rochester MN USA

Funder

National Institute on Aging

National Institutes of Health

Genentech

Alzheimer's Association

Association for Frontotemporal Degeneration

Alzheimer's Drug Discovery Foundation

Pfizer

Nanosomix, Inc.

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2014.06.008

Reference28 articles.

1. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

2. Thinking laterally about neurodegenerative proteinopathies

3. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

4. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

5. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

Cited by 705 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of exosomes derived from stem cells in nerve regeneration: A contribution to neurological repair;Experimental Neurology;2024-10

2. Alzheimer’s disease biomarkers and their current use in clinical research and practice;Molecular Psychiatry;2024-09-04

3. Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study;Journal of Proteomics;2024-09

4. Mechanical properties of blood exosomes and lipoproteins after the rat whole blood irradiation with X-rays in vitro explored by atomic force microscopy;Micron;2024-09

5. Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles;Neurobiology of Disease;2024-09